Analysts/Institutional Investor Meet/Con. Call Updates

Date: July 01, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street Bandra Kurla Complex Mumbai – 400 001 Bandra (E), Mumbai – 400 051 BSE Scrip Code: 544319 NSE Symbol: SENORES Dear Sir/Madam, Sub.: Intimation of Schedule of Analyst / Institutional Investor meetings Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended from time to time, we would like to inform you that the officials of the Company will be meeting Analysts/ Investors (Participants) at its plant at Chhatral, Gujarat and Corporate Office at Ahmedabad, Gujarat as per the details below: Date & Time Nature of Meeting Place Mode of Meeting 07th July, 2026 10:00 A.M. (IST) Group Meeting Ahmedabad, Gujarat Physical onwards Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. Kindly note that changes in the above schedule may happen due to exigencies on the part of Host/ Company. You are requested to take the same on record. Thanking you. For Senores Pharmaceuticals Limited Deval Rajnikant Shah Whole Time Director & CFO DIN: 00332722 Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263